CLL Advocates Network Statement
CLL Advocates Network is closely monitoring the strategies being implemented in various countries to manage the COVID-19 virus. Much of the information about COVID-19 does not address the concerns of people with chronic lymphocytic leukaemia (CLL). With this statement, we wish to fill this gap and provide extra advice for CLL patients.
Most resources agree that the following individuals are at increased risk of severe or fatal COVID-19:
- Older adults (60+ yrs.)
- Individuals with coexisting chronic illnesses (e.g. chronic lung or heart diseases)
- People contracting secondary infections
The following are at high risk of severe or fatal COVID-19:
- Immune depressed individuals
CLL patients – whether treated or not, young or old – are immune depressed. Treatment can add to the immune deficiency. In view of the foregoing, CLL patients are therefore at high risk of getting COVID-19 and having more severe symptoms than the general population.
Further languages will follow.
If you can help translate the statement into your respective language, we would be grateful for support. Please contact us at firstname.lastname@example.org to ask for the editable files.